Health Care & Life Sciences » Pharmaceuticals | Yantai Dongcheng Biochemicals Co. Ltd.

Yantai Dongcheng Biochemicals Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
771
747
788
1,145
1,575
2,305
Cost of Goods Sold (COGS) incl. D&A
600
513
503
625
742
1,027
Gross Income
171
234
285
520
834
1,278
SG&A Expense
72
111
166
298
474
772
EBIT
97
118
114
223
359
506
Unusual Expense
-
-
-
-
6
15
Non Operating Income/Expense
10
3
12
29
22
13
Interest Expense
2
3
7
19
36
55
Pretax Income
125
132
136
243
311
456
Income Tax
21
24
23
42
51
81
Equity in Affiliates
-
-
1
1
4
14
Consolidated Net Income
104
108
112
200
265
389
Net Income
101
104
90
131
173
280
Net Income After Extraordinaries
101
104
90
131
173
280
Net Income Available to Common
101
104
90
131
173
280
EPS (Basic)
0.19
0.20
0.16
0.20
0.25
0.37
Basic Shares Outstanding
518
518
554
665
704
758
EPS (Diluted)
0.19
0.20
0.16
0.20
0.25
0.37
Diluted Shares Outstanding
518
518
554
665
704
758
EBITDA
111
145
149
265
417
590
Other Operating Expense
2
4
5
2
-
-
Non-Operating Interest Income
11
10
10
11
15
23
Minority Interest Expense
3
4
22
69
92
108

About Yantai Dongcheng Biochemicals Co.

View Profile
Address
No. 7 Changbaishan Road
Yantai Shandong 264006
China
Employees -
Website http://www.dcb-group.com
Updated 07/08/2019
Yantai Dongcheng Biochemicals Co., Ltd. engages in the research and development, production, and marketing of biochemical active pharmaceutical ingredient (API). It involves in API, chemical synthetic drugs, and modern chinese medicines. The firm's products include heparin series, chondroitin sulphate, marine collagen, hyaluronic acid, glucosamine series, heparinoid, and cytochrome C.